TargetMol

Fluoxetine HCl

Product Code:
 
TAR-T23570
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T23570-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Fluoxetine HCl is an inhibitor of the first highly specific serotonin uptake.
CAS:
59333-67-4
Formula:
C17H19ClF3NO
Molecular Weight:
345.79
Purity:
0.98
SMILES:
FC(C1=CC=C(OC(C2=CC=CC=C2)CCNC)C=C1)(F)F.[H]Cl

References

1. Lee Y, Rosenblat JD, Lee J, Carmona NE, Subramaniapillai M, Shekotikhina M, Mansur RB, Brietzke E, Lee JH, Ho RC, Yim SJ, McIntyre RS. Efficacy of antidepressants on measures of workplace functioning in major depressive disorder: A systematic review. J Affect Disord. 2017 Nov 7;227:406-415. doi: 10.1016/j.jad.2017.11.003. [Epub ahead of print] Review. PubMed PMID: 29154157. 2. Shafiee M, Arekhi S, Omranzadeh A, Sahebkar A. Saffron in the treatment of depression, anxiety and other mental disorders: Current evidence and potential mechanisms of action. J Affect Disord. 2017 Nov 7;227:330-337. doi: 10.1016/j.jad.2017.11.020. [Epub ahead of print] Review. PubMed PMID: 29136602. 3. Sohel AJ, Molla M. Fluoxetine. 2017 Oct 20. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2017 Jun-. Available from http://www.ncbi.nlm.nih.gov/books/NBK459223/ PubMed PMID: 29083803. 4. Eschlb?ck S, Wenning G, Fanciulli A. Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms. J Neural Transm (Vienna). 2017 Dec;124(12):1567-1605. doi: 10.1007/s00702-017-1791-y. Epub 2017 Oct 22. Review. PubMed PMID: 29058089.